动脉粥样硬化与Salusins相关性研究进展
作者:
作者单位:

(南京医科大学,江苏省南京市 211166)

作者简介:

张瑞,南京医科大学康达学院学生,E-mail为225790093@qq.com。

基金项目:

国家自然科学基金资助项目(31571168)


Research progress of correlation between atherosclerosis and Salusins
Author:
Affiliation:

Nanjing Medical University, Nanjing, Jiangsu 211166, China)

  • 摘要
  • | |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • | |
    摘要:

    动脉粥样硬化是一种常见的心血管疾病,为心脑血管疾病的最主要病理基础,近年来其发病率和死亡率显著上升,成为迫切要解决的关键问题。Salusins是一种新的血管活性肽,大量研究表明在动脉粥样硬化斑块中Salusins高表达,在动脉粥样硬化发生和进展中发挥重要作用,成为一个新的治疗靶点。文章对该领域的最新研究进展做一综述,探讨国内外有关动脉粥样硬化与Salusins的研究现状,并提出未来在该领域中的展望。

    Abstract:

    Atherosclerosis is a common cardiovascular disease, which is the most important pathological basis of cardiovascular and cerebrovascular diseases. In recent years, the incidence and mortality of atherosclerosis has increased significantly, which has become an urgent problem to be solved. Salusins is a new vasoactive peptide which plays an important role in the formation of atherosclerosis. A large number of studies have shown that salusins is highly expressed in atherosclerotic plaques, which plays an important role in the development and progression of atherosclerosis and becomes a new therapeutic target. In this paper, the latest research progress in this field was reviewed, and the research status of atherosclerosis and salusins both domestic and overseas was discussed.

    参考文献
    [1] 吴平生.从《2013 ACC/AHA降低成人动脉粥样硬化性心血管风险胆固醇治疗指南》看血脂管理.中国医院用药评价与分析, 4,4(7):579-580.
    [2] Robinson JG.2013 ACC/AHA cholesterol guideline for reducing cardiovascular risk:what is so controversial?.Curr Atheroscler Rep, 4,6(6):413-415.
    [3] 姜春玲, 原佺.他汀类药物的副作用与临床观察.中国实用医药, 6,1(1):193-194.
    [4] 他汀类药物对肌肉的副作用.中国处方药, 2,0(5):44.
    [5] Nagashima M, Watanabe T, Shiraishi Y, et al.Chronic infusion of salusin-alpha and beta exerts opposite effects on atherosclerotic lesion development in apolipoprotein E-deficient mice.Atherosclerosis, 0,2 (1):70-77.
    [6] Niepolski L, Grzegorzewska AE.Salusins and adropin:New peptides potentially involved in lipid metabolism and atherosclerosis.Adv Med Sci, 6,1(2):282-287.
    [7] Watanabe T, Nishio K, Kanome T, et al.Impact of salusin-αlpha and-beta on human macrophage foam cell formation and coronary atherosclerosis.Circulation, 8,7(5):638-648 .
    [8] Sato K, Koyama T, Tateno T, et al.Presence of immunoreactive salusin-alpha in human serum and urine.Peptides, 6,7(11):2 561-566.
    [9] Watanabe T, Nishio K, Kanome T, et al.Impact of salusin-alpha and-beta on human macrophage foam cell formation and coronary atherosclerosis.Circulation, 8,7(5):638-648.
    [10] Sun HJ, Zhao MX, Liu TY, et al.Salusin-β induces foam cell formation and monocyte adhesion in human vascular smooth muscle cells via miR155/NOX2/NFκB pathway.Sci Rep, 6,3(6):23 596.
    [11] 李浩旭, 鲁彦, 刘江静, 等.Salusin在尾端延髓腹外侧区的心血管效应机制研究.中国药学杂志, 2,7:1 473-477.
    [12] 赵子文, 熊昌, 黄煜, 等.血清salusin-β水平与高血压患者合并冠心病及其严重程度的相关性.山西医科大学学报, 6,7 (12):1 090-093.
    [13] Wang J, Wang Y, Shan S, et al.Salusins protect myocar-dium against ischemic injury by alleviating endoplasmic re-ticulum stress.Sci Chin Life Sci, 2,5:358-366.
    [14] 王世勋.左卡尼汀在动脉粥样硬化及冠心病中的抗炎抗氧化作用.山东大学, 2016.
    [15] 徐超.原发性高血压患者血压变异性与缺血性脑卒中的关系.石河子大学, 2013.
    [16] 邱洪敏, 张晨君, 付建芳.原发性高血压血清Salusin-α水平与动脉功能的相关性研究.细胞与分子免疫学杂志, 0,6 (9):922-923.
    [17] 蒋永林, 蒋荷萍.原发性高血压患者血清Salusin-α、UⅡ与颈动脉IMT的相关性分析.检验医学, 2,7(4):284-286.
    [18] Celik E, Celik O, Yilmaz E, et al.Association of low maternal levels of salusins with gestational diabetes mellitus and with small-for-gestational-age fetuses.Eur J Obstet Gynecol Reprod Biol, 3,7:29-33.
    [19] 唐晓晏,申子刚, 张志仁.炎症消退障碍与动脉粥样硬化不稳定斑块形成.免疫学杂志, 7,3(4):364-368.
    [20] 吴晓乐.人动脉粥样硬化组织HSP70、C-myc蛋白的表达及临床意义.遵义医学院, 2014.
    [21] Niepolski L, Grzegorzewska AE.Salusins and adropin:New peptides potentially involved in lipid metabolism and atherosclerosis.Adv Med Sci, 6,1(2):282-287.
    [22] Pennings M, Meurs I, Ye D, et al.Regulation of cholesterol homeostasis in macrophages and consequences for atherosclerotic lesion development.FEBS Lett, 6,0(23):588-596.
    [23] 弓伊宁, 李芙蓉, 姚伟娟.巨噬细胞的胆固醇代谢及其影响因素.生理科学进展, 6,7(4):291-294.
    [24] 徐敏, 韦舒杰, 张彦, 等.ApoE缺陷大鼠动脉粥样硬化模型的构建.中国动脉硬化杂志, 7,5(1):78-82.
    [25] Shichiri M, Ishimaru S, Ota T, et al.Salusins:newly identified bioactive peptides with hemodynamic and mitogenic activities.Nat Med, 3,9(9):1 166-172.
    引证文献
引用本文

张瑞,陈艾东.动脉粥样硬化与Salusins相关性研究进展[J].中国动脉硬化杂志,2017,25(10):1067~1070.

复制
分享
文章指标
  • 点击次数:1170
  • 下载次数: 880
历史
  • 收稿日期:2017-02-10
  • 最后修改日期:2017-05-07
  • 在线发布日期: 2017-11-28